Pharmaceuticals market research reports by DelveInsight

• Turner Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Turner Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Turner Syndrome – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Turner Syndrome, historical and forecasted epidemiology as well as the Turner Syn ... Read More

• Vertigo – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Vertigo – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Vertigo – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Vertigo, historical and forecasted epidemiology as well as the Vertigo market trends in the Unite ... Read More

• X Linked Hypophosphatemia – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  X Linked Hypophosphatemia – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""X Linked Hypophosphatemia – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the X Linked Hypophosphatemia, historical and forecasted epidemio ... Read More

• Hypersomnia – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Hypersomnia – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Hypersomnia – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Hypersomnia, historical and forecasted epidemiology as well as the Hypersomnia market tre ... Read More

• Hypovolemic Shock – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Hypovolemic Shock – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Hypovolemic Shock – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Hypovolemic Shock, historical and forecasted epidemiology as well as the Hypo ... Read More

• Mucopolysaccharidosis – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Mucopolysaccharidosis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Mucopolysaccharidosis – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Mucopolysaccharidosis, historical and forecasted epidemiology as well ... Read More

• Nonalcoholic Steatohepatitis (NASH) – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Nonalcoholic Steatohepatitis (NASH) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Nonalcoholic Steatohepatitis (NASH) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Nonalcoholic Steatohepatitis (NASH), hist ... Read More

• Bone Resorption – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Bone Resorption – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Bone Resorption – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Bone Resorption, historical and forecasted epidemiology as well as the Bone Resor ... Read More

• BRAF-Mutant Metastatic Melanoma – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  BRAF-Mutant Metastatic Melanoma – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""BRAF-Mutant Metastatic Melanoma – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the BRAF-Mutant Metastatic Melanoma, historical and f ... Read More

• Autoimmune Uveitis – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Autoimmune Uveitis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Autoimmune Uveitis – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Autoimmune Uveitis, historical and forecasted epidemiology as well as the A ... Read More

• Diabetic Neuropathic Pain- Pipeline Insight, 2024

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Diabetic Neuropathic Pain- Pipeline Insight, 2024 DelveInsight’s, “Diabetic Neuropathic Pain- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Diabetic Neuropathic Pain pipeline landscape. It covers the pipeline drug profiles, including cli ... Read More

• Ovarian Granulosa Cell Tumors – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Ovarian Granulosa Cell Tumors – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Ovarian Granulosa Cell Tumors – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Ovarian Granulosa Cell Tumors, historical and forecas ... Read More

• Sickle Cell Disease - Epidemiology Forecast - 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Sickle Cell Disease - Epidemiology Forecast - 2034 Key Highlights In 2023, the United States accounted for the highest number of total prevalent cases of SCD trait with approximately 54% cases found in the 6MM. The prevalence of SCD cases was found to be high and rapidly increasing in the 6MM countr ... Read More

• Alopecia Areata- Pipeline Insight, 2024

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Alopecia Areata- Pipeline Insight, 2024 DelveInsight’s, “Alopecia Areata- Pipeline Insight, 2024” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Alopecia Areata pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pr ... Read More

• Hemophilia B - Pipeline Insight, 2024

  May 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Hemophilia B - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia B - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Hemophilia Bpipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More

• Lewy Body Disease - Pipeline Insight, 2024

  May 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Lewy Body Disease - Pipeline Insight, 2024 DelveInsight’s, “Lewy Body Disease - Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Lewy Body Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More

• Anterior Uveitis - Pipeline Insight, 2024

  May 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anterior Uveitis - Pipeline Insight, 2024 DelveInsight’s, “Anterior Uveitis - Pipeline Insight, 2024” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Anterior Uveitispipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More

• Fragile X Syndrome - Pipeline Insight, 2024

  May 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Fragile X Syndrome - Pipeline Insight, 2024 DelveInsight’s, “Fragile X Syndrome - Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Fragile X Syndromepipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More

• Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024 DelveInsight’s, “Primary Progressive Multiple Sclerosis- Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Primary Progressive Multiple Sclerosis pipeline landscape. It covers t ... Read More

• 5-Alpha Reductase Inhibitor - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  5-Alpha Reductase Inhibitor - Pipeline Insight, 2024 “5-Alpha Reductase Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-Alpha Reductase Inhibitor development. The report p ... Read More

• Transverse Myelitis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Transverse Myelitis - Pipeline Insight, 2024 Transverse Myelitis Overview ""Transverse Myelitis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Transverse Myelitis market. A detailed picture of th ... Read More

• 5-HT2B Antagonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  5-HT2B Antagonist - Pipeline Insight, 2024 “5-HT2B Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2B Antagonist development. The report provides detailed coverage of t ... Read More

• 20s Proteasome Inhibitor - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  20s Proteasome Inhibitor - Pipeline Insight, 2024 “20s Proteasome Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 20s Proteasome Inhibitor development. The report provides d ... Read More

• 5-HT6 Antagonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  5-HT6 Antagonist - Pipeline Insight, 2024 “5-HT6 Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT6 Antagonist development. The report provides detailed coverage of the ... Read More

• Urinary Incontinence Including Neurogenic Bladder - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Urinary Incontinence Including Neurogenic Bladder - Pipeline Insight, 2024 Urinary Incontinence Including Neurogenic Bladder Overview ""Urinary Incontinence Including Neurogenic Bladder Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development sce ... Read More

< prev 44 45 46 47 48 49 50 next >